These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 3298325

  • 1. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
    Byerley WF, Judd LL, Reimherr FW, Grosser BI.
    J Clin Psychopharmacol; 1987 Jun; 7(3):127-37. PubMed ID: 3298325
    [Abstract] [Full Text] [Related]

  • 2. [Serotonin precursors as antidepressive agents: a review].
    Beckmann H, Kasper S.
    Fortschr Neurol Psychiatr; 1983 May; 51(5):176-82. PubMed ID: 6603403
    [Abstract] [Full Text] [Related]

  • 3. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S, Takahashi R, Masumura I, Miike A.
    Folia Psychiatr Neurol Jpn; 1976 May; 30(4):461-73. PubMed ID: 1087913
    [Abstract] [Full Text] [Related]

  • 4. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF, Risch SC.
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [Abstract] [Full Text] [Related]

  • 5. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC.
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [Abstract] [Full Text] [Related]

  • 6. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH, Loftis JM, Blackwell AD.
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [Abstract] [Full Text] [Related]

  • 7. Serotonin and myoclonus.
    Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB.
    Monogr Neural Sci; 1976 Mar; 3():71-80. PubMed ID: 790170
    [Abstract] [Full Text] [Related]

  • 8. The indoleamine hypothesis of depression: an overview and pilot study.
    Zarcone VP, Berger PA, Brodie KH, Sack R, Barchas JD.
    Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
    [Abstract] [Full Text] [Related]

  • 9. In search of the mode of action of antidepressants: 5-HTP/tyrosine mixtures in depression.
    van Praag HM.
    Adv Biochem Psychopharmacol; 1984 Aug; 39():301-14. PubMed ID: 6380226
    [Abstract] [Full Text] [Related]

  • 10. The relationship of serotonin to depression in Parkinson's disease.
    Mayeux R, Stern Y, Sano M, Williams JB, Cote LJ.
    Mov Disord; 1988 Aug; 3(3):237-44. PubMed ID: 2461509
    [Abstract] [Full Text] [Related]

  • 11. Serotonin precursors in the treatment of depression.
    van Praag HM.
    Adv Biochem Psychopharmacol; 1982 Aug; 34():259-86. PubMed ID: 6753514
    [Abstract] [Full Text] [Related]

  • 12. L-5-hydroxytryptophan in depression and anxiety.
    van Praag HM, Kahn RS.
    Schweiz Rundsch Med Prax; 1988 Aug 23; 77(34A):40-6. PubMed ID: 3055148
    [No Abstract] [Full Text] [Related]

  • 13. Instability in the response to DST in major depressions during treatment with 5-hydroxytryptophan and carbidopa.
    Lopez-Ibor JJ, Saiz-Ruiz J, Perez de los Cobos JC.
    Acta Psychiatr Belg; 1985 Aug 23; 85(3):450-8. PubMed ID: 3876688
    [Abstract] [Full Text] [Related]

  • 14. Management of depression with serotonin precursors.
    van Praag HM.
    Biol Psychiatry; 1981 Mar 23; 16(3):291-310. PubMed ID: 6164407
    [Abstract] [Full Text] [Related]

  • 15. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW.
    J Clin Psychiatry; 1987 Mar 23; 48 Suppl():5-11. PubMed ID: 3493240
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ, Jacobs GE, Hoeberechts-Lefrandt DH, de Kam ML, van der Post JP, de Rijk R, van Pelt J, Schoemaker RC, Zitman FG, van Gerven JM, Gijsman HJ.
    J Psychopharmacol; 2008 Jun 23; 22(4):426-33. PubMed ID: 18308795
    [Abstract] [Full Text] [Related]

  • 17. Use of neurotransmitter precursors for treatment of depression.
    Meyers S.
    Altern Med Rev; 2000 Feb 23; 5(1):64-71. PubMed ID: 10696120
    [Abstract] [Full Text] [Related]

  • 18. Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study.
    Nardini M, De Stefano R, Iannuccelli M, Borghesi R, Battistini N.
    Int J Clin Pharmacol Res; 1983 Feb 23; 3(4):239-50. PubMed ID: 6381336
    [Abstract] [Full Text] [Related]

  • 19. Treatment of depression--newer pharmacotherapies.
    Mulrow CD, Williams JW, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.
    Psychopharmacol Bull; 1998 Feb 23; 34(4):409-795. PubMed ID: 10513454
    [Abstract] [Full Text] [Related]

  • 20. ["Precursor therapy" with active amines. I. Treatment of depression by L-5-HTP (L-5-hydroxytryptophan)].
    Sano I.
    Seishin Shinkeigaku Zasshi; 1971 Oct 23; 73(10):809-15. PubMed ID: 5316872
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.